Sirolimus Treatment of Refractory Infantile Hemangiomatosis With Brain Involvement

[1]  E. Roé,et al.  Propranolol‐resistant infantile hemangioma successfully treated with sirolimus , 2020, Pediatric dermatology.

[2]  S. Josephs,et al.  Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates , 2019, Pediatrics.

[3]  E. Monroe.  Brief Description of ISSVA Classification for Radiologists. , 2019, Techniques in vascular and interventional radiology.

[4]  C. Chambers,et al.  Current treatment and management of infantile hemangiomas. , 2019, Survey of ophthalmology.

[5]  J. Ferreira,et al.  Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. , 2019, Journal of vascular surgery.

[6]  M. Vikkula,et al.  Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study , 2018, Orphanet Journal of Rare Diseases.

[7]  M. Wildgruber,et al.  Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies , 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[8]  M. Levy,et al.  Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High‐Dose Propranolol , 2017, Pediatric dermatology.

[9]  C. Chambers,et al.  Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment , 2017, Birth defects research.

[10]  S. Abrams,et al.  Predicting Full Enteral Feeding in the Postoperative Period in Infants with Congenital Diaphragmatic Hernia , 2017, European Journal of Pediatric Surgery.

[11]  R. Azizkhan,et al.  Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies , 2016, Pediatrics.

[12]  A. Mancini,et al.  Diagnosis and Management of Infantile Hemangioma , 2015, Pediatrics.

[13]  D. Rivard,et al.  Vascular malformations: classification and terminology the radiologist needs to know. , 2012, Seminars in roentgenology.

[14]  R. Azizkhan,et al.  Sirolimus for the treatment of complicated vascular anomalies in children , 2011, Pediatric blood & cancer.